Document:

Expense Advance Agreement

 Exhibit 10.1 
 EXPENSE ADVANCEMENT AGREEMENT 
 This EXPENSE ADVANCEMENT AGREEMENT
(“Agreement”), is made this 16th day of December 2011, between WINN-DIXIE STORES, INC., a Florida corporation (the “Company”), and each individual who is a signatory hereto (each, an “Indemnitee”).

 WHEREAS, in connection with each Indemnitee’s service as a member of the Board of Directors of the Company (the
“Board”), the Company agrees with each Indemnitee as follows: 
 1. Advancement of Expenses. In
accordance with Section 7.6 of the amended and restated articles of incorporation of the Company (the “Articles”) and Section 13.6 of the amended and restated by-laws of the Company (the “By-Laws”), the
Company agrees that if any Indemnitee incurs any expenses in defending any civil or criminal proceeding brought in connection with such Indemnitee’s service on the Board, such expenses shall be paid by the Company, to the fullest extent
permitted by law, in advance of the final disposition of such proceeding upon receipt of an undertaking by or on behalf of such Indemnitee to repay such amount if he or she is ultimately found not to be entitled to indemnification by the Company
pursuant to the applicable provisions of the Articles and By-Laws. 
 2. Duration of Agreement. All agreements and
obligations of the Company contained herein shall continue during the period each Indemnitee serves as a member of the Board and shall continue thereafter so long as such Indemnitee shall be or shall become subject to any civil or criminal
proceeding by reason of his or her status as a member of the Board, whether or not such Indemnitee is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification can be provided under this
Agreement. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all
or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal and legal representatives. 
 3. General Provisions. 
 3.1 This Agreement together with the Articles and
By-Laws constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject
matter hereof. 
 3.2 The Company shall not seek from a court a “bar order” which would have the effect of
prohibiting or limiting the Indemnitee’s rights to receive advancement of expenses under this Agreement. 
 3.3 The
invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision. If any provision of this Agreement conflicts with any applicable law, such provision shall be deemed modified,
consistent with the aforementioned intent, to the extent necessary to resolve such conflict. 

 3.4 This Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile or .pdf signature and in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. 
 3.5 No supplement, modification, termination or
amendment of this Agreement shall be binding on any party hereto unless executed in writing by such party. 
 3.6 No waiver of
any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. 

3.7 This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Florida. 

[Signatures Follow] 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

					
	WINN-DIXIE STORES, INC.
		
	By:	 	 /s/ Timothy L. Williams

		 	Name:	 	Timothy L. Williams
		 	Title:	 	SVP, General Counsel and Corporate Secretary

  

	
	INDEMNITEES
	
	 /s/ Evelyn V. Follit

	Evelyn V. Follit
	
	 /s/ Charles P. Garcia

	Charles P. Garcia
	
	 /s/ Jeffrey C. Girard

	Jeffrey C. Girard
	
	 /s/ Yvonne R. Jackson

	Yvonne R. Jackson
	
	 /s/ Gregory P. Josefowicz

	Gregory P. Josefowicz
	
	 /s/ Peter L. Lynch

	Peter L. Lynch
	
	 /s/ James P. Olson

	James P. Olson
	
	 /s/ Terry Peets

	Terry Peets
	
	 /s/ Richard E. Rivera

	Richard E. Rivera

 [Signature Page to Expense Advance Agreement]Loan Security Termination Agreement

 Exhibit 10.85 
 LOAN SECURITY TERMINATION AGREEMENT 
 (Biovest International, Inc.)

 THIS LOAN SECURITY TERMINATION AGREEMENT (this “Agreement”) is made as of December 15, 2011, by
and among LV ADMINISTRATIVE SERVICES, INC., as Administrative and Collateral Agent for the Lenders (“LV”), the LENDERS who are signatories hereto (the “Lenders”), and BIOVEST INTERNATIONAL, INC., a Delaware
corporation (“Biovest”). 
 RECITALS 

WHEREAS, on November 10, 2008, each of Biovest, Biovax, Inc., AutovaxID, Inc., Biolender, LLC and Biolender II, LLC (the
“Biovest Debtors”) commenced a voluntary case for reorganization under Chapter 11 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “Bankruptcy Code”), in the United States
Bankruptcy Court for the Middle District of Florida, Tampa Division (the “Bankruptcy Court”); 

WHEREAS, on August 16, 2010, the Biovest Debtors filed with the Bankruptcy Court their First Amended Joint Plan of
Reorganization of Biovest International, Inc., Biovax, Inc., AutovaxID, Inc., Biolender, LLC, and Biolender II, LLC under Chapter 11 of Title 11, United States Code dated as of August 16, 2010 (the “Biovest Joint Plan”), which
was modified by the First Modification to First Amended Joint Plan of Reorganization of Biovest International, Inc., Biovax, Inc., AutovaxID, Inc., Biolender, LLC, and Biolender II, LLC under Chapter 11 of Title 11, United States Code dated as of
October 25, 2010 (the “Biovest First Modification” and, together with the Biovest Joint Plan, the “Biovest Plan”); 
 WHEREAS, on November 2, 2010, the Bankruptcy Court entered its Order Confirming First Amended Joint Plan of Reorganization of Biovest International, Inc., Biovax, Inc., AutovaxID, Inc.,
Biolender, LLC, and Biolender II, LLC under Chapter 11 of Title 11, United States Code Dated as of August 16, 2010, as Modified, Pursuant to 11 U.S.C. §1129, and the effective date of the Biovest Plan occurred on November 17, 2010;

 WHEREAS, pursuant to the Biovest Plan, on November 17, 2010, LV, Laurus Master Fund Ltd. (In Liquidation), Erato
Corp., PSource Structured Debt Limited, Valens U.S. SPV I, LLC, Valens Offshore SPV I, Ltd., Valens Offshore SPV II, Corp., and Biovest entered into that certain Term Loan and Security Agreement (the “Loan Agreement”), pursuant to
which Laurus Master Fund Ltd. (In Liquidation), Erato Corp., PSource Structured Debt Limited, Valens U.S. SPV I, LLC, Valens Offshore SPV I, Ltd., and Valens Offshore SPV II, Corp. received (i) Secured Term A Notes of Biovest in an aggregate
principal amount of $24,900,000.00 (the “Term A Notes”), and/or (ii) Secured Term B Notes of Biovest in an aggregate principal amount of $4,160,000.00 (the “Term B Notes” and collectively with the Term A Notes,
the “Notes”); 
 WHEREAS, Erato Corp. has assigned its Term A Note dated November 17, 2010, in the
original principal amount of $1,333,334.00, to Calliope Capital Corp.; 
 WHEREAS, the Notes are secured by, among other
things, (i) that certain Grant of Security Interest in Intellectual Property dated as of November 17, 2010 by Analytica International, Inc. (“Analytica”) in favor of LV (the “IP Security Agreement”),
(ii) that certain 

  
 -1-

 
Security Agreement dated November 17, 2010 by Analytica in favor of LV (the “Security Agreement”), and (iii) that certain Guaranty dated November 17, 2010 by
Analytica in favor of LV (the “Guaranty”); 
 WHEREAS, on October 31, 2011, Analytica, LA-SER Alpha
Group Sarl (“LA-SER”) and Accentia Biopharmaceuticals, Inc. (“Accentia”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), which provides for the sale by Analytica, and the
purchase by LA-SER or its designee, of certain of the assets of Analytica free and clear of any liens, claims or encumbrances for an upfront purchase price of $4,000,000.00 plus an Earnout (as such term is defined in the Purchase Agreement);

 WHEREAS, on November 30, 2011, the Bankruptcy Court entered its Order Granting Reorganized Debtors’ Motion
to Approve Sale of Assets of Analytica, Inc., which authorized the execution, delivery and performance of the Purchase Agreement by Accentia and Analytica; and 
 WHEREAS, LV and Accentia entered into that certain letter agreement dated October 19, 2011 (the “Letter Agreement”) pursuant to which the parties agreed that LV and the
Lenders would release certain collateral securing the Notes and terminate certain agreements relating to Analytica in exchange for a payment of not less than $4,000,000.00 (the “Prepayment”), which payment shall be applied to pay
any accrued and unpaid interest on and to reduce the outstanding principal balances of certain secured term notes given by Accentia, an affiliate of Analytica, to PSource Structured Debt Limited, Valens U.S. SPV I, LLC, Calliope Capital Corp. (as
assignee of Erato Corp.) and Valens Offshore SPV II, Corp. pursuant to that certain Loan Prepayment, Modification and Security Termination Agreement of even date hereof. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

1. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Loan Agreement. 

2. The parties hereto agree that the above Recitals are true and correct in all respects. 

3. Upon the receipt of the Prepayment: 
  

	 	a.	LV hereby concurrently terminates the IP Security Agreement and the Security Agreement and releases and discharges any and all liens on the Collateral (as such term is
defined under the IP Security Agreement and the Security Agreement, as applicable) granted to LV under the IP Security Agreement and the Security Agreement as security for the Notes. 

 

	 	b.	LV hereby concurrently terminates the Guaranty and acknowledges and agrees that the Guaranty shall be of no further force and effect after the date hereof.

  

	 	c.	LV and the Lenders hereby irrevocably waive, release and give up all rights to or interests in any and all payments of the Earnout and to the Net Cash (as such term is
defined in the Purchase Agreement). 

 4. Except as specifically amended pursuant to this Agreement and the documents delivered in
connection herewith, the Loan Agreement and each Ancillary Agreement delivered in connection with the closing thereunder shall remain in full force and effect and are hereby ratified and confirmed, and the execution, delivery and effectiveness of
this Agreement shall not operate as a waiver of any right, power or remedy, nor constitute a waiver of any provision of the Loan Agreement or any Ancillary Agreement except as otherwise provided herein. 

5. LV agrees, from time to time after the date hereof, to execute and deliver to Biovest, at the sole cost and expense of Biovest, such
further instruments and documents and to take such further actions as may be reasonably necessary to fully effect the foregoing releases, discharges and terminations. LV and the Lenders acknowledge and agree that the foregoing releases, discharges
and terminations shall be fully binding on LV and the Lenders notwithstanding any provisions in the Loan Agreement or any Ancillary Agreement that require full payment of the Notes prior to the effectiveness of such releases, discharges and
terminations. 
 6. This Agreement shall be binding upon the parties hereto and their respective successors and assigns. The
parties hereto agree that this Agreement is fully and adequately supported by consideration, is fair and reasonable, and that they have had the opportunity to discuss this matter with counsel of their choice. This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original and all of which together shall be deemed to constitute one agreement. It is understood and agreed that if facsimile copies of this Agreement bearing facsimile signatures or e-mails of PDF
copies of signatures are exchanged between the parties hereto, such copies shall in all respects have the same weight, force and legal effect and shall be fully as valid, binding, and enforceable as if such signed facsimile copies were original
documents bearing original signature. 
 7. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED, INTERPRETED AND ENFORCED
ACCORDING TO, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS PROVISIONS THEREOF. ANY ACTION BROUGHT CONCERNING THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT SHALL BE BROUGHT ONLY IN THE STATE COURTS OF NEW
YORK OR IN THE FEDERAL COURTS LOCATED IN THE STATE OF NEW YORK. Wherever possible each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement
shall be prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. 

[remainder of page intentionally left blank] 

 IN WITNESS WHEREOF, the undersigned have executed this Loan Security Termination
Agreement as of the date first above written. 
  

			
	BIOVEST INTERNATIONAL, INC.
		
	 By:
	 	 /s/ David Moser

		 	      Name: David Moser
		 	      Title: Secretary
	
	LV ADMINISTRATIVE SERVICES, INC.
		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory
	
	PSOURCE STRUCTURED DEBT LIMITED
		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory
	
	VALENS U.S. SPV I, LLC
	 By:
	 	Valens Capital Management, LLC,
		 	    its investment manager
		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory
	
	VALENS OFFSHORE SPV I, LTD.
	 By:
	 	Valens Capital Management, LLC,
		 	    its investment manager
		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory

			
	 VALENS OFFSHORE SPV II, CORP.

	 By:
	 	Valens Capital Management, LLC,
		 	    its investment manager
		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory
	
	 LAURUS MASTER FUND LTD.

(In Liquidation)

		
	 By:
	 	 /s/ Russell Smith

		 	      Name: Russell Smith
		 	      Title: Authorized Signatory
	
	 CALLIOPE CAPITAL CORP., as assignee

of ERATO CORP.

		
	 By:
	 	 /s/ Patrick Regan

		 	      Name: Patrick Regan
		 	      Title: Authorized Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]